Last reviewed · How we verify

NCT07306325

Ultrasound in Predicting Difficult Intubation in Acromegaly Patients

Not yet recruiting Last updated 29 December 2025
What this trial tests

trial testing observational study in Acromegaly Due to Pituitary Adenoma in 34 participants. Not yet recruiting.

Timeline
25 December 2025
Primary endpoint
20 March 2026
20 March 2026

Quick facts

Lead sponsorBaşakşehir Çam & Sakura City Hospital
StatusNot yet recruiting
Study typeOBSERVATIONAL
Enrollment34
Start date25 December 2025
Primary completion20 March 2026
Estimated completion20 March 2026
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Başakşehir Çam & Sakura City Hospital

Who can join

Adults 18 to 70, any sex, with Acromegaly Due to Pituitary Adenoma or Difficult Intubation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a prospective observational study.The purpose of this study is to predict difficult intubation with ultrasonographic evaluation combined with preoperative physical examination in patients diagnosed with acromegaly and planned for pituitary surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of observational study

Trials testing the same drug.

Other recruiting trials for Acromegaly Due to Pituitary Adenoma

Currently open trials in the same condition.

Other Başakşehir Çam & Sakura City Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07306325.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing